First Horizon Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5K | Buy |
230
+41
| +22% | +$7.12K | ﹤0.01% | 1106 |
|
|
2025
Q1 | $32K | Buy |
189
+82
| +77% | +$13.5K | ﹤0.01% | 1130 |
|
|
2024
Q4 | $16.2K | Hold |
107
| – | – | ﹤0.01% | 1414 |
|
|
2024
Q3 | $16.7K | Sell |
107
-66
| -38% | -$9.86K | ﹤0.01% | 1437 |
|
|
2024
Q2 | $23.7K | Buy |
173
+8
| +5% | +$1.1K | ﹤0.01% | 1214 |
|
|
2024
Q1 | $22K | Sell |
165
-6
| -4% | -$778 | ﹤0.01% | 1313 |
|
|
2023
Q4 | $23.6K | Sell |
171
-31
| -15% | -$4.08K | ﹤0.01% | 1271 |
|
|
2023
Q3 | $24.6K | Sell |
202
-17
| -8% | -$2.27K | ﹤0.01% | 1160 |
|
|
2023
Q2 | $30.8K | Sell |
219
-632
| -74% | -$87.1K | ﹤0.01% | 1094 |
|
|
2023
Q1 | $120K | Sell |
851
-314
| -27% | -$44.9K | ﹤0.01% | 595 |
|
|
2022
Q4 | $182K | Sell |
1,165
-21
| -2% | -$3.02K | 0.01% | 474 |
|
|
2022
Q3 | $144K | Buy |
1,186
+296
| +33% | +$39K | 0.01% | 515 |
|
|
2022
Q2 | $117K | Buy |
890
+775
| +674% | +$106K | ﹤0.01% | 613 |
|
|
2022
Q1 | $16K | Sell |
115
-7
| -6% | -$976 | ﹤0.01% | 955 |
|
|
2021
Q4 | $20K | Buy |
122
+52
| +74% | +$7.91K | ﹤0.01% | 1274 |
|
|
2021
Q3 | $11K | Buy |
70
+45
| +180% | +$6.58K | ﹤0.01% | 1493 |
|
|
2021
Q2 | $3K | Sell |
25
-710
| -97% | -$93K | ﹤0.01% | 1650 |
|
|
2021
Q1 | $94K | Buy |
+735
| New | +$90.6K | 0.01% | 524 |
|
|
2020
Q1 | – | Sell |
-183
| Closed | -$19K | – | 1408 |
|
|
2019
Q4 | $19K | Sell |
183
-66
| -27% | -$6.88K | ﹤0.01% | 875 |
|
|
2019
Q3 | $26K | Sell |
249
-2
| -0.8% | -$205 | ﹤0.01% | 751 |
|
|
2019
Q2 | $25K | Buy |
251
+43
| +21% | +$4.13K | ﹤0.01% | 794 |
|
|
2019
Q1 | $18K | Buy |
208
+139
| +201% | +$12K | ﹤0.01% | 868 |
|
|
2018
Q4 | $5K | Buy |
69
+17
| +33% | +$1.59K | ﹤0.01% | 1223 |
|
|
2018
Q3 | $5K | Sell |
52
-69
| -57% | -$7.57K | ﹤0.01% | 1299 |
|
|
2018
Q2 | $13K | Buy |
121
+69
| +133% | +$7.19K | ﹤0.01% | 1020 |
|
|
2018
Q1 | $5K | Hold |
52
| – | – | ﹤0.01% | 1200 |
|
|
2017
Q4 | $5K | Hold |
52
| – | – | ﹤0.01% | 1208 |
|
|
2017
Q3 | $4K | Hold |
52
| – | – | ﹤0.01% | 1212 |
|
|
2017
Q2 | $5K | Sell |
52
-12
| -19% | -$1.27K | ﹤0.01% | 1157 |
|
|
2017
Q1 | $6K | Buy |
+64
| New | +$6.1K | ﹤0.01% | 1161 |
|
|
2016
Q2 | – | Sell |
-400
| Closed | -$29K | – | 1343 |
|
|
2016
Q1 | $29K | Sell |
400
-113
| -22% | -$7.58K | ﹤0.01% | 688 |
|
|
2015
Q4 | $35K | Sell |
513
-206
| -29% | -$13.8K | 0.01% | 564 |
|
|
2015
Q3 | $44K | Buy |
719
+206
| +40% | +$14.4K | 0.01% | 561 |
|
|
2015
Q2 | $37K | Sell |
513
-13
| -2% | -$960 | 0.01% | 625 |
|
|
2015
Q1 | $40K | Buy |
526
+6
| +1% | +$430 | 0.01% | 616 |
|
|
2014
Q4 | $35K | Sell |
520
-302
| -37% | -$19.1K | 0.01% | 645 |
|
|
2014
Q3 | $49K | Buy |
822
+40
| +5% | +$2.46K | 0.01% | 526 |
|
|
2014
Q2 | $46K | Buy |
782
+329
| +73% | +$19.3K | 0.01% | 565 |
|
|
2014
Q1 | $26K | Hold |
453
| – | – | ﹤0.01% | 692 |
|
|
2013
Q4 | $23K | Buy |
453
+25
| +6% | +$1.48K | ﹤0.01% | 693 |
|
|
2013
Q3 | $27K | Buy |
+428
| New | +$25.6K | ﹤0.01% | 587 |
|
Other funds holding DGX
First Horizon Advisors's DGX Position: Q2 2025 in Review
First Horizon Advisors increased its Quest Diagnostics (DGX) stake by 22% in Q2 2025, buying an estimated $7.12K and bringing the position to 230 shares worth $41.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.
First Horizon Advisors first reported a position in DGX in Q3 2013 and has held it in 41 quarters since. The position peaked at $182K in Q4 2022. 991 funds tracked by Wall St. Rank hold DGX as of Q2 2025.
- First Horizon Advisors held 230 shares of Quest Diagnostics worth $41.5K as of Q2 2025.
- First Horizon Advisors bought 41 Quest Diagnostics shares in Q2 2025, an estimated $7.12K.
- Quest Diagnostics made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1106 holding.
- First Horizon Advisors first reported a position in Quest Diagnostics in Q3 2013 and has held it in 41 quarters since.
- First Horizon Advisors's Quest Diagnostics position peaked at $182K in Q4 2022.
- 991 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.